Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 146
Immune Disorders Drugs 79
Genomics 78
Biopharmaceuticals 76
Drug Discovery 66
Oncology Drugs 51
Biotechnology 49
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 41
Hematological Drugs 39
Biosimilars and Biosuperiors 30
Alzheimer's Disease Drugs 27
Cardiovascular Drugs 26
Clinical Trials 26
Allergy and Immunology 20
Optical Disorders Drugs 19
Infusions and Injectables 19
Infectious Diseases Drugs 18
Respiratory Drugs 18
Mental Disorders Drugs 18
Gastrointestinal Drugs 17
Needles and Syringes 15
E-Healthcare 14
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Neurology 13
Healthcare Services 13
Drug Delivery 12
Hematology 12
Endocrine and Metabolic Disorders Drugs 12
Lymphoma Drugs 11
Analgesics 10
Leukemia Drugs 9
Optical 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 7
Drugs by Therapeutic Area 7
Pulmonary Medicine 7
Company Reports 6
Enzymes 6
Medical Devices 6
Hospital Management 5
Cardiology 5
Oncology 5
Schizophrenia Drugs 5
Proteomics 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Stem Cells 3
Dermatology 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Skin Cancer Drugs 2
Nanomedicine 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Surgical Procedures 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

905 Results (Page 35 of 46)
- Relevance
  Sort by

Multiple System Atrophy (MSA) - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
January 2025
194 Pages
Global

From

€7354EUR$7,950USD£6,185GBP

DNA Repair Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4154EUR$4,490USD£3,493GBP

Solid Tumor Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4154EUR$4,490USD£3,493GBP

Myeloproliferative Disorders Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4154EUR$4,490USD£3,493GBP

TNF Alpha Inhibitors Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4154EUR$4,490USD£3,493GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Checkpoint Inhibitors Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4154EUR$4,490USD£3,493GBP

Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2025-2033

 Report
May 2025
140 Pages
Global

From

€2774EUR$2,999USD£2,333GBP

Neuroscience Is The Next Oncology: Why Biogen Is Doubling Down

 Newsletter
May 2025
5 Pages
Global

From

€121EUR$131USD£102GBP

Lou Gehrig's Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2775EUR$3,000USD£2,334GBP

Hemophilia Therapeutics Market 2021-2025

 Report
August 2021
120 Pages
Global

From

€2313EUR$2,500USD£1,945GBP

Human Coagulation Factor VII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
93 Pages
Global

From

€3500EUR$4,053USD£3,047GBP

Human Coagulation Factor VIII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
111 Pages
Global

From

€3500EUR$4,053USD£3,047GBP

Human Coagulation Factor IV Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
104 Pages
Global

From

€3500EUR$4,053USD£3,047GBP

Hemophilia B Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
114 Pages
Global

From

€3500EUR$4,053USD£3,047GBP

Antibody Drug Conjugates Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4154EUR$4,490USD£3,493GBP

Biopharmaceuticals Market Report and Forecast 2023-2031

 Report
May 2023
140 Pages
Global

From

€4578EUR$4,949USD£3,850GBP

Ischemia Reperfusion Injury Therapeutics Market Report and Forecast 2024-2032

 Report
September 2023
200 Pages
Global

From

€3329EUR$3,599USD£2,800GBP

Erythromelagia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
November 2023
150 Pages
Global

From

€4487EUR$4,850USD£3,773GBP

Precision Medicine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4394EUR$4,750USD£3,695GBP

Tumor Necrosis Factor Inhibitor Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4154EUR$4,490USD£3,493GBP

905 Results (Page 35 of 46)
- 1
- 33
- 34
- 35
- 36
- 37

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.